Substrates for peptidase M14.009: carboxypeptidase B2
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bradykinin | P01042 | 381-389 | peptide-Phe388+Arg | N | NT | Phe | Ser | Pro | Phe | Arg | - | - | - | Myles et al., 2003 | ||
| Bz-Gly-Arg (hippuryl-Arg) | Bz-Gly+Arg | S | - | - | Bz | Gly | Arg | - | - | - | Hendriks, 2004 | |||||
| Bz-Gly-Lys (hippuryl-Lys) | Bz-Gly+Lys | S | - | - | Bz | Gly | Lys | - | - | - | Hendriks, 2004 | |||||
| C3a anaphylatoxin | P01024 | 672-748 | peptide-Ala747+Arg | N | NT | Leu | Gly | Leu | Ala | Arg | - | - | - | Myles et al., 2003 | ||
| C5a anaphylatoxin | P01031 | 678-751 | peptide-Gly750+Arg | N | NT | Met | Gln | Leu | Gly | Arg | - | - | - | Myles et al., 2003 | ||
| coagulation factor X light chain | P00742 | 41-488 | peptide-Lys+Arg | P | Glu | Arg | Arg | Lys | Arg | - | - | - | Brown et al., 2004 | 17038 | ||
| coagulation factor X light chain | P00742 | 41-488 | peptide-Arg+Lys | P | Leu | Glu | Arg | Arg | Lys | - | - | - | Brown et al., 2004 | 17036 | ||
| coagulation factor X light chain | P00742 | 41-488 | peptide-Glu179+Arg | P | Thr | Leu | Glu | Arg | Arg | - | - | - | Brown et al., 2004 | 17037 | ||
| fibrin derived peptide | Arg-Gly-Asp-Ser-Thr-Phe-Glu-Ser-Lys-Ser-Tyr+Lys | S | Ser | Lys | Ser | Tyr | Lys | - | - | - | Valnickova et al., 2007 | |||||
| Fibrinogen beta chain | P02675 | 169-178 | peptide-Glu177+Lys | N | NT | Ser | Glu | Leu | Glu | Lys | - | - | - | Myles et al., 2003 | ||
| Fibrinogen gamma chain | P02679 | 79-88 | peptide-Ile87+Lys | N | NT | Lys | Gln | Leu | Ile | Lys | - | - | - | Myles et al., 2003 | ||
| Fibrinogen gamma chain | P02679 | 102-111 | peptide-Leu110+Lys | N | NT | Ala | Ala | Thr | Leu | Lys | - | - | - | Myles et al., 2003 | ||
| fibrinogen-derived peptide | P02671 | 590-602 | peptide-Tyr601+Lys | N | MS | Ser | Lys | Ser | Tyr | Lys | - | - | - | Valnickova et al., 2007 | ||
| furylacryloyl-Ala-Arg (FAAR) | furylacryloyl-Ala+Arg | S | - | - | FA | Ala | Arg | - | - | - | Hendriks, 2004 | |||||
| furylacryloyl-Ala-Lys (FAAK) | furylacryloyl-Ala+Lys | S | - | - | FA | Ala | Lys | - | - | - | Hendriks, 2004 | |||||
| N-(4-methoxyphenyl-azoformyl)-Arg-OH | N-(4-methoxyphenyl-azoformyl)+Arg-OH | S | - | - | - | MFA | Arg | - | - | - | Pallares et al., 2005 | |||||
| Osteopontin | P10451 | 160-168 | peptide-Leu167+Arg | N | NT | Val | Tyr | Gly | Leu | Arg | - | - | - | Myles et al., 2003 | ||
| protein S100-A10 | P60903 | 2-97 | peptide-Lys96+Lys | P | Gln | Lys | Gly | Lys | Lys | - | - | - | Fogg et al., 2002 | |||
| protein S100-A10 | P60903 | 2-97 | peptide-Gly95+Lys | P | Lys | Gln | Lys | Gly | Lys | - | - | - | Fogg et al., 2002 |
